Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Japan

As of now, Japan reports a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 13,542.85 million, signifying an increase of 256.56 million (1.9%) from 2021.

Download image Full screen

Play

Source:

Data availability:

Regions:

Date range: 1987 to 2022

Points:

779

Measure:

Constant USD PPP

Similar regions to Japan

More regions

More indicators for Japan

Government R&D in security as % of government support

1.29%

-0.03%

(2021)

Higher-education-finacing R&D financed by general university in local currency

8,171,564.32M

+130,453.60M

(2022)

R&D financed by rest of the world in local currency

1,359,140.00M

+249,200.00M

(2022)

Government R&D financed by rest of the world in local currency

14,730.00M

-7,320.00M

(2022)

Business R&D financed by rest of the world in local currency

1,296,120.00M

+243,210.00M

(2022)

Non-profit R&D growth rate

2.87%

+11.67%

(2022)

More indicators

Japan Business R&D pharmaceutical in constant PPP $ between 1987 and 2022

Period	Value	Change
2022	13,542.85M	+256.56M
2021	13,286.30M	+755.27M
2020	12,531.03M	-285.60M
2019	12,816.63M	-712.32M
2018	13,528.95M	-583.97M
2017	14,112.92M	+1,105.06M
2016	13,007.86M	-1,080.59M
2015	14,088.45M	-668.63M
2014	14,757.08M	+336.00M
2013	14,421.08M	+1,360.27M
2012	13,060.81M	+854.95M
2011	12,205.86M	-251.81M
2010	12,457.67M	+1,023.16M
2009	11,434.51M	-905.78M
2008	12,340.29M	+507.56M
2007	11,832.73M	+835.01M
2006	10,997.72M	+1,263.45M
2005	9,734.27M	+1,410.55M
2004	8,323.72M	+303.25M
2003	8,020.46M	-603.99M
2002	8,624.45M	+1,483.08M
2001	7,141.37M	+641.25M
2000	6,500.12M	+574.72M
1999	5,925.40M	+144.25M
1998	5,781.15M	+322.52M
1997	5,458.63M	-230.97M
1996	5,689.60M	+237.24M
1995	5,452.36M	+107.83M
1994	5,344.53M	+20.67M
1993	5,323.86M	-149.23M
1992	5,473.09M	+369.28M
1991	5,103.81M	+510.75M
1990	4,593.06M	+430.94M
1989	4,162.11M	+284.06M
1988	3,878.05M	+309.31M
1987	3,568.74M